Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |